000 01504 a2200421 4500
005 20250516054208.0
264 0 _c20120619
008 201206s 0 0 eng d
022 _a1477-0970
024 7 _a10.1177/1352458511421920
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPaz Soldán, M Mateo
245 0 0 _aStatin therapy and multiple sclerosis disability in a population-based cohort.
_h[electronic resource]
260 _bMultiple sclerosis (Houndmills, Basingstoke, England)
_cMar 2012
300 _a358-63 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCohort Studies
650 0 4 _aDisability Evaluation
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMinnesota
650 0 4 _aMultiple Sclerosis
_xdrug therapy
650 0 4 _aRetrospective Studies
650 0 4 _aSeverity of Illness Index
700 1 _aPittock, Sean J
700 1 _aWeigand, Stephen D
700 1 _aYawn, Barbara P
700 1 _aRodriguez, Moses
773 0 _tMultiple sclerosis (Houndmills, Basingstoke, England)
_gvol. 18
_gno. 3
_gp. 358-63
856 4 0 _uhttps://doi.org/10.1177/1352458511421920
_zAvailable from publisher's website
999 _c21148387
_d21148387